| scholarly article | Q13442814 |
| P2093 | author name string | O Manor | |
| O Paltiel | |||
| Y Friedlander | |||
| S Harlap | |||
| R Calderon-Margalit | |||
| K Kleinhaus | |||
| M C Perrin | |||
| R Yanetz | |||
| P2860 | cites work | Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study | Q28143163 |
| Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies | Q28280957 | ||
| Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group | Q29619251 | ||
| Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth | Q31034130 | ||
| The Jerusalem Perinatal Study cohort, 1964-2005: methods and a review of the main results | Q34356652 | ||
| Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis | Q34413085 | ||
| Risk of cancer after use of fertility drugs with in-vitro fertilisation | Q34505781 | ||
| Historical perspectives in gonadotrophin therapy | Q35896964 | ||
| Ovulation induction and cancer risk | Q36037710 | ||
| Comparison of uterine malignancies that develop during and following tamoxifen therapy. | Q36341005 | ||
| Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study | Q36614643 | ||
| Cancer incidence following treatment for infertility at a clinic in the UK. | Q38977631 | ||
| Ovulation induction and risk of endometrial cancer: a pilot study | Q43715513 | ||
| Reproductive and dietary risk factors for epithelial ovarian cancer in China | Q44747966 | ||
| Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis | Q44820250 | ||
| Breast cancer risk associated with ovulation-stimulating drugs | Q44952033 | ||
| Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects. | Q45933406 | ||
| Uterine cancer after use of clomiphene citrate to induce ovulation | Q46395953 | ||
| Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001. | Q46605802 | ||
| Cutaneous melanoma in women: ovulatory life, menopause, and use of exogenous estrogens. | Q46643485 | ||
| Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women | Q46788531 | ||
| Hormone replacement therapy and risk of lymphomas and myelomas | Q46968911 | ||
| Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study | Q50545650 | ||
| Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study | Q50547055 | ||
| Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group | Q50563343 | ||
| Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy | Q50761266 | ||
| Risk of ovarian cancer after treatment for infertility. | Q52878571 | ||
| Oral contraceptives and breast cancer: a cooperative Italian study | Q52880273 | ||
| Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients | Q54198450 | ||
| Menstrual and Reproductive Factors and Risk of Non-Hodgkin's Lymphoma among Connecticut Women | Q56994909 | ||
| Risk of endometrial cancer after use of fertility drugs | Q57560651 | ||
| Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group | Q67979093 | ||
| Risk of breast cancer in a cohort of infertile women | Q70888779 | ||
| Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors | Q71745902 | ||
| Ovarian tumors in a cohort of infertile women | Q72139399 | ||
| Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan | Q73505912 | ||
| Cancer Incidence in a Cohort of Infertile Woman | Q74628783 | ||
| TREATMENT OF AMENORRHEA AND OF ANOVULATION WITH HUMAN MENOPAUSAL AND CHORIONIC GONADOTROPINS | Q78265818 | ||
| Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia | Q78519673 | ||
| Ovarian cancer risk after the use of ovulation-stimulating drugs | Q80150828 | ||
| Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer | Q80203510 | ||
| Insurance mandates and trends in infertility treatments | Q80272405 | ||
| Use of clomiphene citrate in women | Q80555761 | ||
| A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs | Q81052922 | ||
| Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs | Q81186160 | ||
| Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women | Q83312024 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 365-375 | |
| P577 | publication date | 2008-11-26 | |
| P1433 | published in | American Journal of Epidemiology | Q4744243 |
| P1476 | title | Cancer risk after exposure to treatments for ovulation induction | |
| P478 | volume | 169 |
| Q44064662 | Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up |
| Q53104592 | Assessing pre‐implantation embryo development in mice provides a rationale for understanding potential adverse effects of ART and PGD procedures |
| Q38694178 | Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. |
| Q38368215 | Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies. |
| Q38081240 | Breast cancer risk after exposure to fertility drugs |
| Q43106184 | Cancer and fertility preservation: international recommendations from an expert meeting |
| Q36240519 | Cancer in women after assisted reproductive technology |
| Q35865978 | Cancer risk among parous women following assisted reproductive technology |
| Q28281796 | Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis |
| Q38223603 | Correlation between fertility drugs use and malignant melanoma incidence: the state of the art. |
| Q37551696 | Current understanding of risk factors for ovarian cancer |
| Q64945254 | Do the Fertility Drugs Increase the Risk of Cancer? A Review Study. |
| Q38499888 | Does ovarian stimulation for IVF increase gynaecological cancer risk? A systematic review and meta-analysis |
| Q37703912 | Does ovulation induction increase the risk of gynecological cancer? |
| Q35620770 | Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro |
| Q36119348 | Effects of fertility drugs on cancers other than breast and gynecologic malignancies |
| Q38007200 | Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome |
| Q33715432 | Female Reproductive Factors and Differentiated Thyroid Cancer |
| Q33846768 | Female infertility. |
| Q55002884 | Fertility Drugs Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis. |
| Q33931378 | Fertility Drugs and the Risk of Breast and Gynecologic Cancers |
| Q37183938 | Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort |
| Q36790599 | Fertility drugs and young-onset breast cancer: results from the Two Sister Study |
| Q33608317 | Fertility drugs, reproductive strategies and ovarian cancer risk. |
| Q48124618 | Frequency of endometrial cancer and atypical hyperplasia in infertile women undergoing hysteroscopic polypectomy. |
| Q33849496 | Genotoxicity of the some selective estrogen receptor modulators: a review |
| Q83998805 | How Long Should Women Persevere with IVF? |
| Q28295207 | IVF and breast cancer: a systematic review and meta-analysis |
| Q33648309 | In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services |
| Q42772069 | Induction of ovulation |
| Q38075778 | Infertility treatment and the risk of cancer |
| Q48583442 | Left out in the cold: arguments against non-medical oocyte cryopreservation. |
| Q37883367 | Long-term complications of assisted reproductive technologies |
| Q37691958 | Long-term relationship of ovulation-stimulating drugs to breast cancer risk |
| Q92605822 | Melanoma Following In Vitro Fertilization: Co-incident or Coincidence? |
| Q41286527 | Melanoma risk after ovarian stimulation for in vitro fertilization. |
| Q37813695 | Ovarian Stimulation: Is There a Long-Term Risk for Ovarian, Breast and Endometrial Cancer? |
| Q64079499 | Ovarian cancer in the world: epidemiology and risk factors |
| Q34369162 | Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort |
| Q37225731 | Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. |
| Q30235061 | Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. |
| Q24200437 | Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility |
| Q49844348 | Safety of clomiphene citrate: a literature review |
| Q34471491 | Social egg freezing: risk, benefits and other considerations |
| Q41595188 | State of the evidence 2017: an update on the connection between breast cancer and the environment |
| Q93016523 | Strong Evidences of the Ovarian Carcinoma Risk in Women after IVF Treatment: A Review Article |
| Q48665827 | The Conundrum of Oocyte Donation, Human Research, OHSS, and Ethics |
| Q45238015 | Transnational Trade in Human Eggs: Law, Policy, and (In)Action in Canada |
| Q34354122 | Use of clomiphene citrate in infertile women: a committee opinion |
| Q50550240 | Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study |
| Q38767310 | Use of fertility medications and cancer risk: a review and update |
Search more.